Telix Pharmaceuticals Limited

TLX | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.31

-$1.28 (-10.17%)

At close: Sep 21, 2026, 4:00 PM ET

$11.91

+$0.60 (+5.31%)

Pre-market: Sep 22, 2026, 6:40 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	212.53M	710.35M	123.24M	116.33M	22.04M	77.95M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	55.57M	6.09M	12.26M	-5.52M	n/a	-4.22M
Other Long-Term Assets	43.18M	74.58M	586K	327K	-3.89M	-6.44M
Receivables	207.29M	158.99M	79.54M	31.14M	20.85M	14.19M
Inventory	55.55M	38.14M	17.31M	5.77M	3.45M	633K
Other Current Assets	n/a	n/a	-7.66M	18.29M	n/a	n/a
Total Current Assets	494.79M	918.56M	224.85M	173.23M	47.54M	93.63M
Property-Plant & Equipment	173.2M	54.32M	30.49M	18.84M	6.33M	4.82M
Goodwill & Intangibles	888.11M	416.13M	109.66M	64.5M	59.83M	63.41M
Total Long-Term Assets	1.28B	597.87M	173.45M	87.36M	62.27M	64.19M
Total Assets	1.77B	1.52B	398.3M	255.35M	109.81M	157.82M
Account Payables	107.36M	68.7M	32.84M	16.81M	11.88M	5.81M
Deferred Revenue	17.18M	11.25M	11M	4.94M	6.14M	3.24M
Short-Term Debt	19.64M	18.99M	964K	636.24K	19K	264K
Other Current Liabilities	99.6M	109.67M	85.7M	46.69M	14.12M	7.65M
Total Current Liabilities	347M	330.91M	157.41M	85.56M	37.98M	19.96M
Long-Term Debt	587.13M	551.82M	8.21M	3.31M	n/a	95K
Other Long-Term Liabilities	35.7M	44.68M	60.02M	54.9M	43.23M	57.41M
Total Long-Term Liabilities	801.64M	617.31M	91.98M	89.79M	68.19M	58.85M
Total Liabilities	1.15B	948.22M	249.39M	175.35M	106.17M	78.81M
Total Debt	699.77M	581.45M	17.45M	10.45M	2.54M	2.21M
Book Value	622.27M	568.21M	148.91M	80.01M	3.64M	79.02M
Book Value Per Share	1.84	1.65	0.46	0.26	0.01	0.31
Common Stock	719.03M	596.78M	446.27M	370.97M	170.84M	167.06M
Retained Earnings	-231.51M	-212.96M	-263.67M	-272.82M	-173.47M	-92.96M
Comprehensive Income	134.76M	184.4M	-33.69M	-18.15M	4.79M	4.92M
Shareholders Equity	622.27M	568.21M	148.91M	80.01M	2.16M	79.02M
Total Investments	55.57M	6.09M	12.26M	-5.52M	n/a	-4.22M